Sage Therapeutics, Inc. (SAGE)

NASDAQ: SAGE · IEX Real-Time Price · USD

13.33

+0.29 (2.26%)

At close: Apr 19, 2024, 4:00 PM

13.35

+0.02 (0.15%)

After-hours: Apr 19, 2024, 5:01 PM EDT

Sage Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Cash & Equivalents	72.32	163.97	295.5	1,663	129.07	193.31	307.08	169.08	186.79	127.81	Upgrade
Short-Term Investments	682.19	1,110	1,448	438.47	881.69	731.83	212.61	228.96	0	0	Upgrade
Cash & Cash Equivalents	754.52	1,274	1,744	2,101	1,011	925.14	519.7	398.04	186.79	127.81	Upgrade
Cash Growth	-40.76%	-26.94%	-17.02%	107.89%	9.25%	78.02%	30.56%	113.09%	46.15%	1476.87%	Upgrade
Receivables	83.01	13.66	18.51	0	0	0	0	0	0	0	Upgrade
Other Current Assets	31.83	49.56	38.57	21.11	24.33	19.55	5.38	4.54	1.7	1.02	Upgrade
Total Current Assets	869.35	1,337	1,801	2,122	1,035	944.7	525.08	402.58	188.49	128.82	Upgrade
Property, Plant & Equipment	6.38	13.43	19.13	31.82	42.9	5.64	4.01	1.39	0.29	0.16	Upgrade
Other Long-Term Assets	6.55	6.04	5.52	5.06	6.16	2.37	0.85	0.56	0.24	0.68	Upgrade
Total Long-Term Assets	12.93	19.47	24.65	36.88	49.06	8.01	4.86	1.95	0.53	0.84	Upgrade
Total Assets	882.28	1,356	1,825	2,159	1,084	952.71	529.94	404.53	189.02	129.67	Upgrade
Accounts Payable	10.32	18.95	10.45	3.69	15.27	34.04	9.35	12.82	5.16	2.43	Upgrade
Current Debt	5.17	7.64	7.47	8.66	10.24	0	0	0	0	0	Upgrade
Other Current Liabilities	67.26	72.67	67.28	54.85	86.62	51.99	42.6	22.35	10.15	5.33	Upgrade
Total Current Liabilities	82.75	99.26	85.19	67.2	112.13	86.03	51.95	35.17	15.31	7.76	Upgrade
Long-Term Debt	0	4.49	10.96	19.44	26.85	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	0	0.1	0.1	0.27	0.52	3.7	2.51	0.85	0.01	0.02	Upgrade
Total Long-Term Liabilities	0	4.59	11.06	19.71	27.37	3.7	2.51	0.85	0.01	0.02	Upgrade
Total Liabilities	82.75	103.85	96.26	86.91	139.5	89.73	54.46	36.01	15.32	7.78	Upgrade
Total Debt	5.17	12.13	18.43	28.1	37.09	0	0	0	0	0	Upgrade
Debt Growth	-57.43%	-34.17%	-34.41%	-24.24%	-	-	-	-	-	-	Upgrade
Retained Earnings	-2,569.66	-2,028.17	-1,495.39	-1,037.49	-1,643.57	-963.33	-590.45	-320.33	-161.34	-66.85	Upgrade
Comprehensive Income	-0.81	-10.21	-2.66	0.42	1.3	-0.52	-0.03	-0.1	0	0	Upgrade
Shareholders' Equity	799.53	1,253	1,729	2,072	944.66	862.97	475.48	368.52	173.7	121.89	Upgrade
Net Cash / Debt	749.35	1,262	1,725	2,073	973.67	925.14	519.7	398.04	186.79	127.81	Upgrade
Net Cash / Debt Growth	-40.60%	-26.87%	-16.79%	112.92%	5.25%	78.02%	30.56%	113.09%	46.15%	1476.87%	Upgrade
Net Cash Per Share	12.52	21.27	29.40	39.11	19.15	20.06	13.64	11.88	6.72	5.92	Upgrade
Working Capital	786.6	1,238	1,715	2,055	922.97	858.67	473.12	367.41	173.18	121.07	Upgrade
Book Value Per Share	13.36	21.12	29.47	39.87	18.58	18.71	12.47	11.00	6.25	5.65	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).